Plasma Fatty Acid-Binding Protein 4 Increases with Renal Dysfunction in Type 2 Diabetic Patients without Microalbuminuria | Zendy

Anna Cabré | Zendy; Iolanda Lázaro | Zendy; Josefa Girona | Zendy; Josep M. Manzanares | Zendy; Francesc Marimón | Zendy; Núria Plana | Zendy; Mercedes Heras | Zendy; L. Masana | Zendy

Open Access

Plasma Fatty Acid-Binding Protein 4 Increases with Renal Dysfunction in Type 2 Diabetic Patients without Microalbuminuria

Author(s) -

Anna Cabré,

Iolanda Lázaro,

Josefa Girona,

Josep M. Manzanares,

Francesc Marimón,

Núria Plana,

Mercedes Heras,

L. Masana

Publication year - 2007

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2007.094672

Subject(s) - microalbuminuria , medicine , renal function , albuminuria , creatinine , endocrinology , type 2 diabetes , diabetes mellitus , proteinuria , kidney disease , urology , gastroenterology , kidney

Fatty acid-binding protein 4 (FABP4) has been linked to metabolic syndrome development, diabetes, and arteriosclerosis, but the role of FABP4 in target organ damage has not been assessed. We evaluated whether plasma FABP4 is associated with renal dysfunction in type 2 diabetic patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research